MENU
+Compare
IFRX
Stock ticker: NASDAQ
AS OF
Jul 18, 01:31 PM (EDT)
Price
$0.85
Change
-$0.02 (-2.30%)
Capitalization
58.8M

IFRX InflaRx NV Forecast, Technical & Fundamental Analysis

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR... Show more

Industry: #Biotechnology
IFRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for IFRX with price predictions
Jul 17, 2025

Momentum Indicator for IFRX turns positive, indicating new upward trend

IFRX saw its Momentum Indicator move above the 0 level on June 27, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 102 similar instances where the indicator turned positive. In of the 102 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where IFRX's RSI Oscillator exited the oversold zone, of 35 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The Moving Average Convergence Divergence (MACD) for IFRX just turned positive on June 23, 2025. Looking at past instances where IFRX's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IFRX advanced for three days, in of 220 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IFRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

IFRX broke above its upper Bollinger Band on July 08, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.719) is normal, around the industry mean (17.995). P/E Ratio (0.000) is within average values for comparable stocks, (59.169). IFRX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.515). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (344.828) is also within normal values, averaging (275.695).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. IFRX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IFRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
IFRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

IFRX is expected to report earnings to rise 33.00% to -17 cents per share on July 31

InflaRx NV IFRX Stock Earnings Reports
Q2'25
Est.
$-0.17
Q1'25
Beat
by $0.04
Q4'24
Beat
by $0.16
Q3'24
Missed
by $0.05
Q2'24
Missed
by $0.04
The last earnings report on May 07 showed earnings per share of -12 cents, beating the estimate of -17 cents. With 66.00K shares outstanding, the current market capitalization sits at 58.80M.
A.I. Advisor
published General Information

General Information

a developer of biopharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Winzerlaer Strasse 2
Phone
+49 3641508180
Employees
66
Web
https://www.inflarx.de
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ADFJF5.61N/A
N/A
ADF Group Inc.
LSIIF37.13N/A
N/A
Lisi
MHGVY19.19-0.01
-0.05%
Mowi ASA
CRZY30.00-0.12
-0.41%
Crazy Woman Creek Bancorp Inc.
CNLHP36.00-0.38
-1.04%
Connecticut Light & Power Co. (The)

IFRX and Stocks

Correlation & Price change

A.I.dvisor tells us that IFRX and NNVC have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IFRX and NNVC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IFRX
1D Price
Change %
IFRX100%
+2.11%
NNVC - IFRX
30%
Poorly correlated
+2.50%
LXEO - IFRX
28%
Poorly correlated
+1.19%
VERA - IFRX
28%
Poorly correlated
+0.85%
ALLO - IFRX
28%
Poorly correlated
+0.81%
TENX - IFRX
26%
Poorly correlated
+0.51%
More